IK1 inhibitor PA-6

立即咨询

IK1 inhibitor PA-6

本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。

CAS NO:

500715-03-7

包装与价格：

包装	价格(元)
10mM (in 1mL DMSO)	电议
5mg	电议
10mg	电议
25mg	电议
50mg	电议

产品介绍

IK1 inhibitor PA-6 (PA-6) 是一种喷他脒类似物，是有效的、选择性的 IK1 (KIR2.x离子通道携带向内整流电流) 抑制剂，人和老鼠中对KIR2.x 电流的 IC50 值为 12-15 nM。IK1 inhibitor PA-6 (PA-6) 可上调 KIR2.1 的蛋白表达，诱导细胞内KIR2.1 的蛋白的积累。IK1 inhibitor PA-6 (PA-6) 有治疗房颤和心律失常的潜力。

Cas No.	500715-03-7
别名	PA-6
Canonical SMILES	N=C(C1=CC=CC=C1)NC2=CC=C(OCCCCCOC3=CC=C(NC(C4=CC=CC=C4)=N)C=C3)C=C2
分子式	C₃₁H₃₂N₄O₂
分子量	492.61
溶解度	DMSO: 125 mg/mL (253.75 mM)
储存条件	Store at -20℃
General tips	For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition	Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
产品描述	IK1 inhibitor PA-6 (PA-6), a pentamidine analogue, is a selective and potent IK1 (KIR2.x ion-channel-carried inward rectifier current) inhibitor, with IC50 values of 12-15 nM for human and mouse KIR2.x currents. IK1 inhibitor PA-6 (PA-6) elevates KIR2.1 protein expression and induces intracellular KIR2.1 accumulation. IK1 inhibitor PA-6 (PA-6) has the potential to treat atrial fibrillation and arrhythmia[1][2][3]. [1]. Takanari H, et al. Efficient and specific cardiac IK? inhibition by a new pentamidine analogue. Cardiovasc Res. 2013 Jul 1;99(1):203-14. [2]. Ji Y, et al. The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in goat and dog models. Br J Pharmacol. 2017 Aug;174(15):2576-2590. [3]. Ji Y, et al. PA-6 inhibits inward rectifier currents carried by V93I and D172N gain-of-function KIR2.1 channels, but increases channel protein expression. J Biomed Sci. 2017 Jul 15;24(1):44.